Europe Infusion Pump Market Projected to Reach USD 7.09 Billion by 2031
Europe's infusion pump market is projected to reach USD 7.09 billion by 2031 at a 6.8% CAGR. Growth is driven by connected systems, tighter safety standards, homecare use, and diabetes demand.
The Europe infusion pump market is projected to reach USD 7.09 billion by 2031 from USD 5.11 million in 2026, growing at a CAGR of 6.8%. The rapid expansion of the market is driven by technological advancements, evolving healthcare delivery models, and demographic shifts across the region.
The introduction of sophisticated, interconnected infusion systems has been transformative, with these devices increasingly integrating with electronic health records and hospital IT infrastructures widely used in European healthcare systems. This integration supports precise dosing, enables real-time monitoring, and enhances clinical decision-making, improving patient safety while streamlining workflows for healthcare providers.
Regulatory authorities in Europe are intensifying their focus on patient safety, interoperability, and cybersecurity standards for infusion pumps, particularly under frameworks such as the EU Medical Device Regulation (MDR). Given the critical role these devices play in administering a wide range of medications, stringent regulatory requirements are in place to mitigate risks from medication errors and cybersecurity vulnerabilities.
Another significant driver of market growth is the shift of treatment delivery from hospital settings to homecare and ambulatory settings, especially for chronic conditions such as diabetes, cancer, cardiovascular diseases, and autoimmune disorders. This trend is closely linked to Europe’s aging population, which has a higher prevalence of chronic illnesses and increasingly favors home-based care for long-term disease management.
By type, the accessories & consumables segment accounted for the largest market share in 2025. The major share attributed to infusion pump disposables is linked to their indispensable role in the safety and effectiveness of healthcare medication administration in Europe. This segment includes essential components such as infusion sets, catheters, tubing, and connectors, most of which are single-use products and thus require frequent replacement to ensure patient safety and minimize the risk of healthcare-associated infections.
By application, the diabetes management segment is expected to grow at the highest CAGR during the forecast period. Rising incidence of diabetes and rapid innovation in insulin infusion technology in Europe are major drivers of this segment, including hybrid closed-loop systems and automated insulin delivery systems, which enable an immediate change in the insulin infusion rate based on glucose concentration.
Increased access to insulin pumps with simpler interfaces, more advanced touch screens, improved basal infusion rate management, and mobile connectivity has made patients more comfortable, leading to better therapy adherence. In addition, demographic shifts, including an aging population, lifestyle factors, and rising obesity rates, have all contributed to a growing pool of diabetic patients, driving demand for insulin infusion pumps at an accelerated rate and sustaining a positive trend in application.